The GMP cytokines market was valued at US$ 84.72 million in 2019 and it is estimated to grow at a CAGR of 8.1% from 2020 to 2027.
GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches. Moreover, these are used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions. The growth of the GMP cytokines market is mainly attributed to the factors such as increase in acceptance of cytokines cancer and autoimmune therapies, and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.
Lucrative Regions for GMP Cytokines Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies
Cytokines play significant role in the regulation of innate and adaptive immunity, which enable cells of the immune system to communicate over short distances. The cytokine therapy to activate the immune system of cancer patients has been an essential parameter in the treatment of cancer and continues to be a prime contributor to present clinical cancer research. Interferon-alpha is one of the approved cytokines for the adjuvant treatment of refractory malignancies. Several research activities have proved the ability of cytokines to limit tumor cell growth by a direct anti-proliferative or pro-apoptotic activity. Moreover, some cytokines inhibit the tumor growth indirectly by stimulating the cytotoxic activity of immune cells against tumor cells. This effectiveness of cytokines therapies over cancer coupled with increasing prevalence of the disease is likely to drive the market by 2027. According to the World Health Organization, in 2019, approximately 9.6 million deaths across the globe were due to cancer.
Additionally, increasing number of investments and collaborations to develop cytokine therapies over cancer and autoimmune diseases are also expected to accelerate the market growth. For instance, in September 2020, Synthekine Inc. raised US$ 82.0 million through rounds of series funding. The company is engaged in the development of cytokine therapeutics for the treatment of cancer and autoimmune disorders.
Type -Based Insights
Based on type, the GMP cytokines market is segmented into TNF, interleukin, growth factor, and others. The growth factors segment held the largest share of the market in 2019; whereas, the TNF segment is anticipated to register the highest CAGR of 8.7% in the market during the forecast period.
GMP Cytokines Market, by Type – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application-Based Insights
Based on application, the GMP cytokines market is segmented into cell and gene therapy, tissue-engineered products, and others. The cell and gene therapy segment held the largest share of the market in 2019; whereas, the tissue engineered products segment is anticipated to register the highest CAGR in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
GMP Cytokines Market: Strategic Insights
Market Size Value in US$ 84.72 Million in 2019 Market Size Value by US$ 158.13 Million by 2027 Growth rate CAGR of 8.1% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
GMP Cytokines Market: Strategic Insights
Market Size Value in | US$ 84.72 Million in 2019 |
Market Size Value by | US$ 158.13 Million by 2027 |
Growth rate | CAGR of 8.1% from 2020-2027 |
Forecast Period | 2020-2027 |
Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystProduct launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Collaboration is one of the major strategies adopted by the GMP cytokines market players to enlarge customer base worldwide, which also permits them to maintain their brand name globally.
GMP Cytokines Market – by Type
- TNF
- Interleukins
- Growth Factors
- Others
GMP Cytokines Market – by Application
- Cell and Gene Therapy
- Tissue Engineered Products
- Others
GMP Cytokines Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Miltenyi Biotec
- Sino Biological Inc.
- ABCAM
- PeproTech Inc.
- Akron Biotech
- CellGenix GmbH
- BIO-TECHNE CORPORATION
- CREATIVE BIOARRAY
- Proteintech Group Inc.
- REPROCELL Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type , and Application , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures and other therapeutic approaches. Moreover, these are also used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions
The global GMP cytokines market growth is mainly attributed to factors such as increase in acceptance of cytokines cancer and autoimmune therapies and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.
The GMP cytokines market majorly consists of the players such as Miltenyi Biotec, Sino Biological, Inc., ABCAM, PeproTech, Inc., Akron Biotech, CellGenix GmbH, BIO-TECHNE CORPORATION, CREATIVE BIOARRAY, Proteintech Group, Inc., and REPROCELL Inc. among others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global GMP Cytokines Market – By Type
1.3.2 Global GMP Cytokines Market – By Application
1.3.3 Global GMP Cytokines market – By Geography
2. GMP Cytokines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global GMP Cytokines – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. GMP Cytokines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies
5.1.2 Potential Contribution in Stem Cell Therapy
5.2 Market Restraints
5.2.1 High Cost Associated with GMP Cytokines Therapy
5.3 Market Opportunities
5.3.1 Extensive Pipeline of Drug Candidates for Cytokines Therapeutics
5.4 Future Trends
5.4.1 Utilization of Cytokines as Biomarkers
5.5 Impact Analysis
6. GMP Cytokines Market – Global Analysis
6.1 Global GMP Cytokines Market Revenue Forecast And Analysis
6.2 Global GMP Cytokines Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. GMP Cytokines Market Analysis – By Type
7.1 Overview
7.2 GMP Cytokines Market Revenue Share, by Type (2019 and 2027)
7.3 TNF
7.3.1 Overview
7.3.2 TNF: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Interleukin
7.4.1 Overview
7.4.2 Interleukin: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Growth Factor
7.5.1 Overview
7.5.2 Growth Factor: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8. GMP Cytokines Market Analysis – By Application
8.1 Overview
8.2 GMP Cytokines Market Revenue Share, by Application (2019 and 2027)
8.3 Cell/Gene Therapy
8.3.1 Overview
8.3.2 Cell/Gene Therapy: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Tissue-Engineered Products
8.4.1 Overview
8.4.2 Tissue-Engineered Products: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Tissue-Engineered Products: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
9. GMP Cytokines Market – Geographic Analysis
9.1 North America GMP Cytokines Market Revenue And Forecasts To 2027
9.1.1 North America GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 North America GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.3 North America GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.4 North America GMP Cytokines Market Revenue and Forecasts to 2027, By Country (%)
9.1.5 US GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.5.1 US GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.5.2 US GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.5.3 US GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.6 Canada GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 Canada GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 Canada GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 Canada GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.7 Mexico GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Mexico GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Mexico GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 Mexico GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2 Europe GMP Cytokines Market Revenue And Forecasts To 2027
9.2.1 Europe GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.2 Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.3 Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.4 Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Country (%)
9.2.5 UK GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.5.1 UK GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.5.2 UK GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.5.3 UK GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.6 Germany GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.1 Germany GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.2 Germany GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.6.3 Germany GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.7 France GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 France GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.2 France GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.7.3 France GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.8 Italy GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.1 Italy GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.2 Italy GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.8.3 Italy GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.9 Spain GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.1 Spain GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.2 Spain GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.9.3 Spain GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.10 Rest of Europe GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.10.1 Rest of Europe GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.10.2 Rest of Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.10.3 Rest of Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3 Asia Pacific: GMP Cytokines Market
9.3.1 Overview
9.3.2 Asia Pacific: GMP Cytokines Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.3.4 Asia Pacific: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.3.5 Asia Pacific GMP Cytokines Market Revenue and Forecasts to 2027, By Country (%)
9.3.6 China: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.3.6.3 China: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.3.7 Japan: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.3.7.3 Japan: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.3.8 India: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.3.8.3 India: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.3.9 South Korea: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.3.9.3 South Korea: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.3.10 Australia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.3.10.3 Australia: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.3.11 Rest of Asia Pacific: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.11.1 Rest of Asia Pacific: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.3.11.2 Rest of Asia Pacific: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.3.11.3 Rest of Asia Pacific: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.4 Middle East & Africa: GMP Cytokines Market
9.4.1 Overview
9.4.2 Middle East & Africa: GMP Cytokines Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East & Africa: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.4.4 Middle East & Africa: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.4.5 Middle East & Africa: GMP Cytokines Market Share by Country – 2019 & 2027, (%)
9.4.6 Saudi Arabia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.4.6.3 Saudi Arabia: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.4.7 UAE: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.4.7.3 UAE: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.4.8 South Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
9.4.8.1 South Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.4.8.3 South Africa: GMP Cytokines Market, by Application , 2018–2027 (USD Million)
9.4.9 Rest of Middle East and Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
9.4.9.1 Rest of Middle East and Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.4.9.2 Rest of Middle East and Africa: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.4.9.3 Rest of Middle East and Africa: GMP Cytokines Market, by Application , 2018–2027 (USD Million)
9.5 South and Central America: GMP Cytokines Market
9.5.1 Overview
9.5.2 South and Central America: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.5.4 South and Central America: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.5.5 South and Central America: GMP Cytokines Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.5.6.3 Brazil: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.5.7 Argentina: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.5.7.3 Argentina: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.5.7.4 Rest of South and Central America: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.5 Rest of South and Central America: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.6 Rest of South and Central America: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.5.7.7 Rest of South and Central America: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on Global GMP Cytokines Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. GMP Cytokines Market– Industry Landscape
11.1 Overview
11.1 Growth Strategies Done by the Companies in the Market, (%)
11.2 Organic and Inorganic Developments
11.2.1 Overview
12. Company Profiles
12.1 Miltenyi Biotec
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sino Biological Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 ABCAM
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PeproTech, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Akron Biotech
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 CellGenix GmbH
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 BIO-TECHNE CORPORATION
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 CREATIVE BIOARRAY
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Proteintech Group, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 REPROCELL, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 2. North America GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 3. US GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 4. US GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 5. Canada GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 6. Canada GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 7. Mexico GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 8. Mexico GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 9. Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 10. Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 11. UK GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 12. UK GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 13. Germany GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 14. Germany GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 15. France GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 16. France GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 17. Italy GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 18. Italy GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 19. Spain GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 20. Spain GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 21. Rest of Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 22. Rest of Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 23. Asia Pacific GMP Cytokines Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 24. Asia Pacific GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. China GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 26. China GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 27. Japan GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. Japan GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 29. India GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 30. India GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 31. South Korea GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 32. South Korea GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 33. Australia GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 34. Australia GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 35. Rest of Asia Pacific GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Rest of Asia Pacific GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 37. Middle East & Africa GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 38. Middle East & Africa GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 39. Saudi Arabia GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 40. Saudi Arabia GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 41. UAE GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 42. UAE GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 43. South Africa GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 44. South Africa GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 45. Rest of Middle East and Africa GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 46. Rest of Middle East and Africa GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 47. South and Central America GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 48. South and Central America GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 49. Brazil: GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 50. Brazil: GMP Cytokines Market, by Application, – Revenue and Forecast to 2027 (USD Million)
Table 51. Argentina: GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 52. Argentina: GMP Cytokines Market, by Application, – Revenue and Forecast to 2027 (USD Million)
Table 53. Rest of South and Central America: GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of South and Central America: GMP Cytokines Market, by Application, – Revenue and Forecast to 2027 (USD Million)
Table 55. Organic and Inorganic Developments Done By Companies
Table 56. Glossary of Terms, GMP Cytokines Market
LIST OF FIGURES
Figure 1. GMP Cytokines Market Segmentation
Figure 2. GMP Cytokines Market Segmentation, By Region
Figure 3. GMP Cytokines Market Overview
Figure 4. TNF Segment by Type Segment Expected to Witness Rapid Growth
Figure 5. APAC to Show Significant Growth During Forecast Period
Figure 6. GMP Cytokines Market, by Geography (US$ Million)
Figure 7. Global GMP Cytokines Market – Leading Country Markets (US$ Million)
Figure 8. Global GMP Cytokines Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. GMP Cytokines Market Impact Analysis of Drivers and Restraints
Figure 15. Global GMP Cytokines Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global GMP Cytokines Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global GMP Cytokines Market
Figure 18. GMP Cytokines Market Revenue Share, by Type (2019 and 2027)
Figure 19. TNF: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Interleukin: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Growth Factor: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. GMP Cytokines Market Revenue Share, by Application (2019 and 2027)
Figure 24. Cell/Gene Therapy: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Rotating Arm: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Rotating Arm: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. North America GMP Cytokines Market Revenue Overview, by Country, 2019 (US$ Mn)
Figure 28. North America GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. North America GMP Cytokines Market Revenue and Forecasts to 2027, By Country (%)
Figure 30. US GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Canada GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. Mexico GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Europe GMP Cytokines Market Revenue Overview, by Country, 2019 (US$ MN)
Figure 34. Europe GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Country (%)
Figure 36. UK GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Germany GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. France GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Italy GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. Spain GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Rest of Europe GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. Asia Pacific: GMP Cytokines Market, by Key Country – Revenue (2019) (USD Million)
Figure 43. Asia Pacific GMP Cytokines Market Revenue and Forecast to 2027 (USD Million)
Figure 44. Asia Pacific: GMP Cytokines Market, by Country, 2019& 2027 (%)
Figure 45. China: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Japan: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. India: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. South Korea: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Australia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. Rest of Asia Pacific: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Middle East & Africa: GMP Cytokines Market, by Key Country – Revenue (2019) (USD Million)
Figure 52. Middle East & Africa GMP Cytokines Market Revenue and Forecast to 2027 (USD Million)
Figure 53. Middle East & Africa: GMP Cytokines Market Share by Country – 2019 & 2027, (%)
Figure 54. Saudi Arabia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. UAE: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 56. South Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. Rest of Middle East and Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. South and Central America: GMP Cytokines Market, by Key Country – Revenue (2019) (USD Million)
Figure 59. South and Central America GMP Cytokines Market Revenue and Forecast to 2027 (USD Million)
Figure 60. South and Central America: GMP Cytokines Market, by Country, 2019 & 2027 (%)
Figure 61. Brazil: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 62. Argentina: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 63. Rest of South and Central America: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. Impact of COVID-19 Pandemic in North America Country Markets
Figure 65. Impact of COVID-19 Pandemic in European Country Markets
Figure 66. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 67. Impact Of COVID-19 Pandemic in Rest of the World Market
Figure 68. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - GMP Cytokines Market
- Miltenyi Biotec
- Sino Biological Inc.
- ABCAM
- PeproTech Inc.
- Akron Biotech
- CellGenix GmbH
- BIO-TECHNE CORPORATION
- CREATIVE BIOARRAY
- Proteintech Group Inc.
- REPROCELL Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to GMP Cytokines Market
Jan 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jan 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jan 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)